期刊
BIOCHEMICAL SOCIETY TRANSACTIONS
卷 38, 期 -, 页码 955-961出版社
PORTLAND PRESS LTD
DOI: 10.1042/BST0380955
关键词
aggregation; Alzheimer's d sease; fragmentation; proteolysis; tau; tauopathy
资金
- Max-Planck-Gesellschaft Breuer Foundation
- Metlife Foundation
- European Union
- Bundesministerium fur Bildung und Forschung (Kompetenz Netzwerk Neurodegenerative Demenzen)
Tau aggregation is a hallmark of several neurodegenerative diseases, including AD (Alzheimer's disease), although the mechanism underlying tau aggregation remains unclear. Recent studies show that the proteolysis of tau plays an important role in both tau aggregation and neurodegeneration. On one hand, truncation of tau may generate amyloidogenic tau fragments that initiate the aggregation of tau, which in turn can cause toxicity. On the other hand, truncation of tau may result in tau fragments which induce neurodegeneration through unknown mechanisms, independently of tau aggregation. Blocking the truncation of tau thus may represent a promising therapeutic approach for AD or other tauopathies. In the present paper, we summarize our data on tau cleavage in a cell model of tauopathy and major results on tau cleavage reported in the literature.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据